Stock IPO IP GROUP PLC
Add to a list
To use this feature you must be a member
Log inSign up

News IP Group Plc

Equities

IPO

GB00B128J450

Investment Management & Fund Operators

Market Closed - London S.E.
Other stock markets
 11:35:04 2024-12-02 am EST 		5-day change 1st Jan Change
45.60 GBX +3.64% Intraday chart for IP Group Plc +5.80% -21.51%
Nov. 18 IP Group investee AMSL Aero completes first free flight of Vertiia AN
Oct. 30 DiffBlue Limited announced that it has received $6.3 million in funding from IP Group Plc, University of Oxford, Parkwalk Advisors Ltd, AlbionVC, Oxford Investment Consultants LLP, and other investors CI

Search
See the results
Unlock all the news: Be the first to know and act before the market!
100% Free Registration
IP : Oxford Nanopore and UK Biobank to create world's largest epigenetic dataset targeting the causes of cancer, dementia, complex disease
Nov. 27
 PU
IP : C-Capture’s technology in biofuels trial to achieve net zero
Nov. 20
 PU
IP Group investee AMSL Aero completes first free flight of Vertiia
Nov. 18
 AN
IP : Microbiotica Announces First Patient Dosed in its Phase 1b Trial (COMPOSER-1) of MB310, a Precision Microbiome Medicine, in Ulcerative Colitis Patients
Nov. 13
 PU
IP : STORM Therapeutics Presents New Clinical Data on its First in Class METTL3 Inhibitor STC 15 at SITC 2024
Nov. 12
 PU
IP : Oxford Nanopore announces senior leadership changes
Nov. 12
 PU
IP : New strategic partnership between UK Biobank, Genomics England, NHS England and Oxford Nanopore
Nov. 05
 PU
IP : Ieso Digital Health Appoints Kent Tangen as New CEO to Drive Digital Mental Health Innovation in the United States
Nov. 04
 PU
IP : Diffblue Secures $6.3 Million in New Funding Amidst 3x Growth Period
Oct. 30
 PU
DiffBlue Limited announced that it has received $6.3 million in funding from IP Group Plc, University of Oxford, Parkwalk Advisors Ltd, AlbionVC, Oxford Investment Consultants LLP, and other investors
Oct. 29
 CI
IP : Oxa Unveils Autonomous Ford E-Transit Van and Minibus
Oct. 29
 PU
IP : Dr. Falk Pharma acquires Kynos Therapeutics, adding acute pancreatitis as a therapeutic focus and further strengthening its development portfolio
Oct. 29
 PU
Dr. Falk Pharma GmbH acquired Kynos Therapeutics Ltd from Epidarex Capital, IP Group Plc and Scottish Investment Bank Limited.
Oct. 28
 CI
IP : Alimetry raises US$18m for next phase of growth
Oct. 24
 PU
IP : Quantum Dice and SCI Semiconductor announce partnership to bring quantum-backed cryptography to advanced security systems
Oct. 22
 PU
IP : STORM Therapeutics to Present Phase 1 Data on its First in Class Lead Product STC 15 at EORTC NCI AACR Symposium
Oct. 09
 PU
IP Group extends share buyback by GBP10 million amid exits
Oct. 07
 AN
IP Group Launches Follow-on GBP10 Million Share Buyback Scheme
Oct. 07
 MT
IP Group Plc announces an Increase in Equity Buyback.
Oct. 06
 CI
IP : AMSL Aero Signs International Partnership with Philippines Bases Conversion and Development Authority
Oct. 03
 PU
IP : Intelligent Ultrasound Group plc - Completion of sale of Clinical AI Business
Oct. 01
 PU
IP : Genomics Announces David Thornton as President
Oct. 01
 PU
Visa acquires Featurespace, providing returns for IP Group, Chrysalis
Sep. 26
 AN
IP Group Expects GBP134 Million From Visa's Acquisition of Featurespace
Sep. 26
 MT
Visa Inc. (NYSE:V) signed a definitive agreement to acquire Featurespace from from Chrysalis Investments Limited, Highland Europe (UK) LLP, IP Group Plc, Insight Venture Management, LLC, MissionOG Capital, LLC, and TTV Capital LLC.
Sep. 25
 CI
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. IPO Stock
  4. News IP Group Plc
Exceptional Extension | BLACK FRIDAY -40% : Unlock Tomorrow's Top Investments with Our Exclusive Subscriber-Only Tools!
d
:
:
BENEFIT NOW